Abstract Synovial sarcoma (SS) is initiated by a t(X;18) chromosomal translocation and resultant SS18-SSX fusion oncogene. Only a few SS cell lines exist. None has been compared to its source tumor. In order to compare matched tumor and cell line pairs, we performed RNAseq on 3 tumor/cell line pairs from a genetically engineered mouse model of SS, as well as 2 pairs from human SS tumors. Transcriptomes of mouse tumors and derivative cell lines deviated significantly. Differentially expressed genes highlighted inflammatory infiltrates and metabolism. The same was found for the human tumor and cell line pairs. More was shared between different tumors than between any tumor and its cell line. Direct xenografting generated transcriptomes that more closely resembled the primary tumor than did its derivative cell line. SS tumor transcriptomes are powerfully impacted by the environment wherein they reside, especially with regard to immune interaction and metabolism.
Introduction
Most discovery biology and therapy-evaluating science related to cancer begins in cell lines derived from tumors. The process of developing these cell lines necessarily introduces departures from the biology of the cancer cells in their native tumor environment [1] . Such changes have yet to be extensively studied, despite our reliance on the faithful recapitulation of tumor biology in cell culture models.
As the most common and most deadly soft-tissue sarcoma in the adolescent and young adult population [2] , SS merits the development of better therapeutic options, which have not improved in many decades [3] . Driven by SS18-SSX fusion genes generated by characteristic t(X;18) chromosomal translocations, SS is considered a genome-stable malignancy harboring few other genetic changes [4] [5] [6] . There is strong homogeneity, both genetic and histomorphologic among the cells in any given SS [7] . This stability and homogeneity proffer tacit confidence that the biology of derivative cell lines in culture represents SS tumor biology well.
However, SSs have proven difficult to culture, suggesting that the cells that ultimately grow in vitro may have been selected to have many departures from their native biology [8] . We turned to a source of multiplied opportunities for culturing fresh tumors: a genetically engineered mouse model of synovial sarcomagenesis.
Methods

Human Synovial Sarcomas
Human tumors were collected with the approval of the institutional review board from consented patients and in accordance with legal and ethical standards. Each human case was clinically Huifeng Jin and Jared J. Barrott co-first authors confirmed to bear the characteristic chromosomal translocation by fluorescent in situ hybridization for the break-apart SS18 probe. Each of the included cases was later confirmed to express the SS18-SSX1 fusion, specifically, by RT-PCR.
Mice
Mouse experiments were conducted with the approval of the institutional animal care committee in accordance with legal and ethical standards. The previously described, Rosa26 hSS1 ;Myf5Cre + and Rosa26
hSS2
;Myf5Cre + mice were maintained on a mixed strain background, C57BL/6 and SvJ.
Genotyping was performed as previously described [4] . Expression of the fusion was confirmed by expression in each tumor of GFP, which is expressed from the same transcript as each SS18-SSX fusion oncogene. Of the included tumors, M1 and M2 were derived from SS18-SSX1-expressing mice and M3 from an SS18-SSX2-expressing mouse. Xenografts were initiated by dicing freshly harvested human SSs into 1-2 mm 3 fragments and embedding each subcutaneously into the flank of an NSG mouse.
Transcriptome Analyses
Total RNA was isolated with the RNeasy mini kit (Qiagen, Valencia, CA, USA), prepared using the Illumina TruSeq RNA kit (Illumina, San Diego, CA, USA), checked with the Agilent Bioanalyzer RNA 6000 chip (Agilent Technologies, Santa Clara, CA, USA), captured using the RiboZero method (Illumina), and 50-cycle end-read sequenced on an Illumina HiSeq 2000. Reference fasta files were generated by combining the chromosome sequences from mm10 with all possible splice junction sequences, which were generated with USeq (v8.8.8) MakeTranscriptome using a radius of 46 and annotated with Ensembl transcripts (build 74) from the UCSC browser. Reads were aligned with Novoalign (v2.08.01), allowing up to 50 alignments per read. USeq's SamTranscriptomeParser selected the best alignment for each and converted the coordinates of reads aligning to splices back to genomic space. Differential g e n e e x p r e s s i o n w a s m e a s u r e d u s i n g U S e q 's DefinedRegionDifferentialSeq. Briefly, the number of reads aligned to each gene were calculated, then normalized in DESeq2. R package 'pheatmap' (v1.0.2) generated heatmaps. Log2 (FPKM) values were centered and scaled by gene. Significance was tested with a right tailed Fisher Exact Test and p-value correction according to the Benjamini-Hochberg method for multiple testing [9, 10] . Function Dist in DeSeq2 package in R was used to calculate the Euclidean distance between samples and to provide an overview of similarities and dissimilarities between samples for the hierarchical clustering.
Notably, the RNAseq data from the human xenografts was aligned only to the human genome, making possible the filtering out of transcriptomic contributions from the murine infiltrating inflammatory, stromal, and endothelial cells. However, the human and mouse genomes for coding sequence are sufficiently homologous to make the clear separation between transcripts from these cells very unlikely from 50 bp reads.
Histology
Tissues were fixed in 4% paraformaldehyde overnight, and embedded in paraffin. Paraffin-embedded tissues were stained by immunohistochemistry by rehydrating slides through a citrosolv and ethanol dilution wash. Antigen-retrieval was performed in 10 mM sodium citrate (pH 6.0). Slides were blocked in 5% normal goat serum/0.3% Triton X-100/phosphate buffered saline, immunostained with anti-GFP antibody (Santa Cruz Biotechnologies, sc-8334, Santa Cruz, CA, USA), detected by horse radish peroxidase and hematoxylin counterstained. Light photomicrographs were obtained with an Olympus BX43 microscope and DP26 camera (Olympus America, Center Valley, PA, USA). From the mouse tumors, we cannot know whether the specific tumor segment that was dissociated and cultured was monophasic or biphasic. Because the bulk of each tumor was divided between snap frozen and culture samples, only the periphery of the tumors with their invasion into the surrounding host tissues are processed for histology. These analyses demonstrated monophasic synovial sarcoma histology for each specimen, but we know that approximately half of tumors in these mice likely had biphasic areas in the core of the tumor as well. Both human tumors were monophasic synovial sarcomas.
Flow Cytometry
Primary tumors were minced, and single cell suspensions generated using enzymatic and mechanical dissociation (Tumor Dissociation Kit and GentleMACS Tissue Homogenizer, Miltenyi Biotec, San Diego, CA, USA). Cells were strained using 70 μm MACS Smart strainers (Miltenyi Biotec), washed with PBS and 0.5 mg/mL bovine serum albumin, and stained with (10 μL for 10 6 cells) E-caderin-APC (R&D Systems, FAB7481A, Minneapolis, MN, USA) and DAPI. Flow cytometry was performed on a BD Facs Canto instrument (BD Bioscience, San Jose, CA, USA), and analyzed using FlowJo 8.7.1. E-cadherin positivity was established using a no antibody control sample. GFP is an intrinsically expressed fluorochrome and E-cadherin is a surface protein; thus, no permeabilization was required.
Cell Lines
Human cell lines were maintained in Dulbecco's modified eagle medium (DMEM) with 10% or 20% fetal bovine serum (FBS), and validated for the expression of and dependence (siRNA) on SS18-SSX1. The three mouse cell lines were similarly established and maintained in DMEM with 20% FBS. Each was validated for fusion gene expression by RT-PCR.
Results
To determine the composition of SSs developing in mice, we utilized the GFP reporter that is expressed with the SS18-SSX fusion. Immunohistochemistry against GFP identified greater than 90% of cells as stained in both histologic subtypes of SS, monophasic (only mesenchymal) and biphasic (including both mesenchymal and epithelial areas) (Fig. 1a-c) .
A high fraction of tumor cells was also demonstrated by flow cytometry for GFP fluorescence (Fig. 1d) . The slightly lower tumor cell fraction by flow cytometry was anticipated due to the relative filtering out of incompletely dissociated tumor cells embedded in matrix. Freshly harvested SSs from the mice were divided into samples for snap freezing to enable subsequent total RNA procurement and for immediate dissociation and culture. Of 6 attempts at culture, 3 successfully generated passageable cell lines that retained SS18-SSX expression.
Freshly harvested human SSs were divided into 3 samples each, for snap freezing, dissociation and culturing, and immediate xenograft implantation into NSG mice. The success rate of generating passageable cell lines was only 2 of 10, but both of these primary tumors also grew as xenograft implantations. Histology of other samples from the two tumors that grew demonstrated monophasic SSs, with very high percentage of apparent tumor cells.
Transcriptome sequencing revealed a large number of genes (10,883 for mouse, and 8834 for human) to be differentially expressed by at least 2-fold and p < 0.05 significance in cell lines compared to the original tumors. Heatmaps revealed that in both mouse and human pairs, differentially expressed genes shared directional changes in each tumor-cell comparison (Fig. 2a) . Venn diagram analysis demonstrated 5072 out of 10,883 total altered genes were shared at the same level of stringency in all three tumor-cell comparisons in the mouse (Fig. 2b) . The two human comparisons shared 2525 out of 8834 (Fig. 2b) . Hierarchical cluster analysis segregated cell lines from tumors (Fig. 2c) . Ingenuity Pathway Analysis (IPA) found that differentially expressed genes associated with multiple pathways (Table 1) , but highlighted inflammatory infiltrates and metabolism ( Fig. 3 and Table 1 ).
We next tested if the transcriptional shift in cultured cells could be rescued by the xenograft environment. Hierarchal clustering of human cell lines, xenografted tumors, and primary tumors more closely associated the latter two (Fig. 2c) . The yet differentially expressed genes most prominently featured metabolism (Table 2) . 
Discussion
There is an on-going debate about what constitutes the most appropriate preclinical model for the study of cancer. Our data are not the first to indicate that cell lines fail in some respects to recapitulate tumor biology. In a prior study, only 34 of 60 cancer cell line expression profiles reflected well the tumor types they represented [11] . Here, transcriptome data from 3 mouse and 2 human SS tumor-to-cell line matched pairs identified broad deviations, but mostly related to the microenvironment, such as inflammatory infiltrates and metabolism. Prior transcriptome profiling work has described gene expression patterns shared across various SS cases. Highlighted genes have included those involved in epithelial differentiation (such as ERBB2, IGFBP2/3 and EGFR), neural differentiation (such as neurofilament, ephrinB3 and EphA4), and tumor markers (TLE1, Keratin, etc.) [12] [13] [14] [15] . Our analyses found few alterations in the expression of these core genes (except for ephrin pathway genes, see Table 1 ). This suggests that SS-derived cells in culture largely maintain the Bmolecular signature^of SS tumors and that expression of these signature genes is regulated by intrinsic transcriptional regulatory programs that function independently from culture or in vivo conditions.
Our data revealed considerable variation in gene expression profiles overall and the enrichment of microenvironment modification-related genes among those differentially expressed genes across all examined tumor-to-cell line comparisons. Among the most differentially regulated genes are those related to inflammatory infiltrates and metabolism (Fig. 3) , indicating cellular heterogeneity and interactions as well as energy/nutrition conditions may play a critical role in gene expression in SS tumors. While we hoped to be able to distinguish the contributions from infiltrating cells in the xenografted human tumors, complete exclusion of transcriptomic contributions from murine infiltrating cells is impossible due to the strong homology between mouse and human coding sequences. Further, while tumor infiltrating lymphocytes are rare in synovial sarcomas, they would be especially rare in the immune compromised host mice for xenografts.
Because much of drug discovery work begins in cell lines, as the science pertinent to the interaction of the microenvironment and drug responses develops, we should bear in mind the magnitude of its impacts even on tumors with relatively strong homogeneity and few stromal and immune infiltrates.
